NUS NU SKIN ENTERPRISES, INC.
Industrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries
NU SKIN ENTERPRISES, INC. (NUS) is a industrials company in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry, with a market capitalization of $244 million. Shares last traded at $5.03, 65.4% below their 52-week high. Over the past year the stock is down 35.3%. NUS trades at a price-to-earnings ratio of 1.52, below the Wholesale-Drugs, Proprietaries & Druggists' Sundries median of 18.97. Net profit margin is 10.8%, above the peer median of 0.9%. Revenue declined 14.3% year over year. The shares yield 27.6% in dividends.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q1 2026 | $0.04 | 2026-05-08 |
| FY 2025 | $3.18 | 2026-02-13 |
| Q3 2025 | $2.91 | 2025-11-07 |
| Q2 2025 | $2.59 | 2025-08-08 |
| Q1 2026 | $2.14 | 2026-05-08 |
| FY 2025 | $-2.95 | 2026-02-13 |
Wholesale-Drugs, Proprietaries & Druggists' Sundries peers
NUS vs 9 industry peers (Wholesale-Drugs, Proprietaries & Druggists' Sundries), by market cap.
| MCK | McKesson Corporation | $90.3B | 18.97 | 0.22 | 1.2% | -3.64% |
| COR | Cencora | $52.9B | 34.04 | 0.16 | 0.5% | -1.90% |
| CAH | Cardinal Health | $52.3B | 33.50 | 0.23 | 0.7% | -1.84% |
| HLF | Herbalife Ltd. | $1.2B | 5.40 | 0.24 | 4.5% | +2.41% |
| WGRX | Wellgistics Health, Inc. | $429M | — | — | — | -7.46% |
| NUS | NU SKIN ENTERPRISES, INC. | $244M | 1.52 | 0.16 | 10.8% | +1.11% |
| HWH | HWH International Inc. | $12M | — | — | — | -5.95% |
| COSM | Cosmos Health Inc. | $11M | -0.57 | 0.17 | -29.3% | -7.76% |
| HKPD | Cellyan Biotechnology Co., Ltd | — | — | — | — | -2.63% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.